VYOME HOLDINGS, INC. Other Selling, General and Administrative Expense
VYOME HOLDINGS, INC. (HIND) had Other Selling, General and Administrative Expense of $30.00 thousand as of 2026-02-28, per its 10-Q filed 2026-05-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- VYOME HOLDINGS, INC. other selling, general and administrative expense for fiscal 2025 was $100.00K.
| Period end | Other Selling, General and Administrative Expense | Other Selling, General and Administrative Expense 1 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2026-02-28 | $30.00K 10-Q · filed 2026-05-12 | ||
| 2026-01-31 | $30.00K 10-Q · filed 2026-08-12 | ||
| 2025-12-31 | $100.00K 10-Q · filed 2026-05-12 | $100.00K 10-Q · filed 2026-08-12 | $100.00K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |